Cytomx Therapeutics Share Price Today
(NASDAQ: CTMX)
Cytomx Therapeutics share price is $0.71 & ₹60.67 as on 26 Apr 2025, 2.30 'hrs' IST
$0.71
Market is closed - opens 7 PM, 28 Apr 2025
View live Cytomx Therapeutics share price in Dollar and Rupees. Guide to invest in Cytomx Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cytomx Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.
Cytomx Therapeutics share price movements
- Today's Low: $0.70Today's High: $0.77
0.77%
Downside
Day's Volatility :8.46%
Upside
7.74%
- 52 Weeks Low: $0.4052 Weeks High: $5.85
43.66%
Downside
52 Weeks Volatility :93.16%
Upside
87.86%
Cytomx Therapeutics (CTMX) Returns
Cytomx Therapeutics (CTMX) Key Statistics
in dollars & INR
How to invest in Cytomx Therapeutics Stock (CTMX) from India?
It is very easy for Indian residents to invest directly in Cytomx Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cytomx Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cytomx Therapeutics or CTMX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cytomx Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Cytomx Therapeutics shares which would translate to 1.204 fractional shares of Cytomx Therapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cytomx Therapeutics, in just a few clicks!
Returns in Cytomx Therapeutics (CTMX) for Indian investors in Rupees
The Cytomx Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
Investment Value
₹1,00,000
Cytomx Therapeutics investment value today
Current value as on today
₹46,657
Returns
Returns from Cytomx Therapeutics Stock
Dollar Returns
₹2,558 (+2.56%)
Indian investors sentiment towards Cytomx Therapeutics (CTMX)
Global Institutional Holdings in Cytomx Therapeutics
TANG CAPITAL MANAGEMENT LLC
9.13%
Bvf Inc
6.53%
Vanguard Group Inc
6.44%
Prosight Management, LP
4.88%
Millennium Management LLC
4.02%
Point72 Asset Management, L.P.
3.31%
Analyst Recommendation on Cytomx Therapeutics
Hold
46%Buy
53%Hold
0%Sell
Based on 13 Wall street analysts offering stock ratings for Cytomx Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Cytomx Therapeutics Stock (CTMX)
What analysts predicted
Upside of 569.01%
Target:
$4.75
Current:
$0.71
Insights on Cytomx Therapeutics Stock (Ticker Symbol: CTMX)
Price Movement
In the last 7 days, CTMX stock has moved down by -4.6%Increasing Revenue
Revenue is up for the last 3 quarters, 25.11M → 38.09M (in $), with an average increase of 18.6% per quarterIncreasing Net Profit
Netprofit is up for the last 3 quarters, -6.53M → 18.87M (in $), with an average increase of 141.8% per quarterCTMX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 130.6%CTMX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 75.8% return, outperforming this stock by 135.8%Price to Sales
ForCTMX every $1 of sales, investors are willing to pay $0.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.3 for every $1 of sales.
Cytomx Therapeutics Technicals Summary
Sell
Neutral
Buy
Cytomx Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Cytomx Therapeutics (CTMX) Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 13.9% | -29.16% | -55.56% | -58.16% | -93.49% |
 | -5.01% | -35.12% | -32.5% | -8.6% | 16.72% |
 | -10.1% | 12.64% | 56.32% | 52.93% | 51.4% |
 | 1.86% | 3.67% | 24.65% | 80.75% | 96.71% |
 | -6.78% | -12.27% | 70.81% | 88.64% | 85.33% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 2.02 | 2.02 | -1.8 | 0.18 | -54.75 | 0.1 | NA | -0.01 |
| 15.65 | 15.65 | 0.96 | 39.99 | 0.16 | 0.07 | 0.01 | 273.57 |
| NA | NA | NA | 1.09 | -0.19 | -0.06 | NA | 31.22 |
| 32.84 | NA | 1.35 | 17.95 | -0.03 | 0.13 | NA | 63.87 |
| NA | NA | -0.49 | 0.72 | -15.01 | -0.03 | NA | 0.52 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Hold | $61.3M | -93.49% | 2.02 | 23.08% |
| Buy | $65.6B | 16.72% | 15.65 | 31.07% |
| NA | $29.1B | 51.4% | NA | -16.92% |
| Buy | $126.6B | 96.71% | 32.84 | -4.86% |
| Buy | $31.4B | 85.33% | NA | -12.37% |
About Cytomx Therapeutics
Management People of Cytomx Therapeutics
Important FAQs about investing in CTMX Stock from India :
What is Cytomx Therapeutics share price today?
Cytomx Therapeutics share price today stands at $0.71, Open: $0.77 ; Previous Close: $0.77 ; High: $0.77 ; Low: $0.70 ; 52 Week High: $5.85 ; 52 Week Low: $0.40.
The stock opens at $0.77, after a previous close of $0.77. The stock reached a daily high of $0.77 and a low of $0.70, with a 52-week high of $5.85 and a 52-week low of $0.40.
Can Indians buy Cytomx Therapeutics shares?
Yes, Indians can invest in the Cytomx Therapeutics (CTMX) from India.
With INDmoney, you can buy Cytomx Therapeutics at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Cytomx Therapeutics at zero transaction cost.
How can I buy Cytomx Therapeutics shares from India?
It is very easy to buy Cytomx Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Cytomx Therapeutics (CTMX) be purchased?
Yes, you can buy fractional shares of Cytomx Therapeutics with INDmoney app.
What are the documents required to start investing in Cytomx Therapeutics stocks?
To start investing in Cytomx Therapeutics, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What are today’s High and Low prices of Cytomx Therapeutics Stock (CTMX)?
Today’s highest price of Cytomx Therapeutics (CTMX) is $0.77.
Today’s lowest price of Cytomx Therapeutics (CTMX) is $0.70.
What is today's market capitalisation of Cytomx Therapeutics?
What is the 52 Week High and Low Range of Cytomx Therapeutics Stock (CTMX)?
52 Week High
$5.85
52 Week Low
$0.40
What are the historical returns of Cytomx Therapeutics (CTMX)?
1 Month Returns
13.9%
3 Months Returns
-29.16%
1 Year Returns
-55.56%
5 Years Returns
-93.49%
Who is the Chief Executive Officer (CEO) of Cytomx Therapeutics ?
Discover More
- Drx Dly Transports Bull 3x
$17.70
-6.56%
- Capitol Ser Tr The Nightview Fd
$26.65
+2.39%
Ab Us Low Volatility Equity Etf$68.82
+0.85%
Cohen & Steers Closed-end Op$11.54
+0.61%
Grupo Televisa, S.a.b.$1.99
+2.05%
Utime Ltd$2.05
+28.12%
Fidelity Msci Real Estate Etf$26.37
-0.23%
Invesco Db Precious Metals Fund$74.06
-1.07%
- United States 12 Month Natur
$8.42
+0.72%